Geno Pharmaceuticals Private Limited

Geno Pharmaceuticals Private Limited - pharma in Goa, India. FY 2026 financials & compliance.
CIN U24239GA1975PTC000250 Incorporated 04 December 1975 ROC Goa HQ Goa, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹349.47 Cr
▲ 14% YoY
Net profit · FY 2025
₹36.05 Cr
Net margin 10.3%
EBITDA · FY 2025
₹56.27 Cr
EBITDA margin 16.1%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹136.64 Cr
Satisfied ₹96.95 Cr
Company age
51 yrs
Est. 1975
Employees · EPFO
1,042
Provident fund records

About Geno Pharmaceuticals Private Limited

Data last updated:

Geno Pharmaceuticals Private Limited is a private limited company based in Goa, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 December 1975 and has been in existence for over 51 years.

The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24239GA1975PTC000250. Its GSTIN is 30AAACG5887G1ZO (Goa). The company holds 25 GST registrations, of which 20 are active.

The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹3 Cr. It was formerly known as Geno Pharmaceuticals Limited. It is led by directors including Sagar Dilip Salgaocar (Managing Director) and Pramod Dilip Salgaocar (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tivim Industrial Estatekasarwada Mapusa, Goa, India.

As per the financials filed for FY 2025, the company reported a revenue of ₹349.47 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹36.05 Cr (net margin 10.3%) and EBITDA of ₹56.27 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 12% over five years.

The company has about 1,042 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Geno Pharmaceuticals. As per MCA filings, the company has open charges of ₹136.64 Cr and satisfied charges of ₹96.95 Cr on record. Court records list 85 cases involving the company, including 55 filed by the company and 30 filed against it; 13 cases are pending.

Geno Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GA-01-0002168). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genopharma.com.

Company details

CIN U24239GA1975PTC000250
Registration Number 000250
Incorporation Date 04 December 1975
ROC Goa
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GA-01-0002168

CIN history

Geno Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239GA1975PTC000250, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239GA1975PTC000250Current
L24239GA1975PLC000250Previous
U24239GA1975PLC000250Previous
Key People
Sagar Dilip Salgaocar Managing Director Pramod Dilip Salgaocar Whole-Time Director Pallavi Sagar Salgaocar Whole-Time Director

Recognitions & Rankings of Geno Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-GA-01-0002168

Contact details

Geno Pharmaceuticals Private Limited's registered office is in Goa. Its website is genopharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    genopharma.com
  • Registered Address
    Tivim Industrial Estatekasarwada Mapusa, Goa, India
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Geno Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Geno Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Geno Pharmaceuticals operates one associated brand: Geno Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Geno Pharmaceuticals
Pharmaceutical manufacturing, healthcare solutions, and veterinary services in India.genopharma.com

Business activity

The main business activity of Geno Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Geno Pharmaceuticals Private Limited, buy the company report.

Financials of Geno Pharmaceuticals Private Limited

FY 2025 filings available

Geno Pharmaceuticals Private Limited reported revenue of ₹349.47 Cr (up 14% YoY) for FY 2025.

Revenue · FY 2025
₹349.47 Cr ▲ 14%
Net profit · FY 2025
₹36.05 Cr margin 10.3%
EBITDA · FY 2025
₹56.27 Cr margin 16.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 10%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 113%
3 years · compounded
▲ 41%
5 years · compounded
▲ 49%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 14% growth in the latest year. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹56.27 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹36.05 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin16.1%
Net Profit Margin10.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Geno Pharmaceuticals Private Limited, buy the company report.

Board of directors of Geno Pharmaceuticals Private Limited

Geno Pharmaceuticals has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dilip Salgaocar Ramacrisna
Also directs: Geno Sports Club
Director01 Jan 198046 Years 10 MonthsCurrent
Sagar Dilip Salgaocar
Also directs: Geno Sports Club, Estilo Moderno Ventures Private Limited, Sharvani Buildcon Private Limited and 2 more
Managing Director01 Oct 201016 Years 1 MonthsCurrent
Pramod Dilip SalgaocarWhole-Time Director30 Sep 200620 Years 1 MonthsCurrent
Shivam Sagar SalgaocarDirector23 Oct 20233 Years 0 MonthsCurrent
Pallavi Sagar Salgaocar
Also directs: Estilo Moderno Ventures Private Limited, Sharvani Buildcon Private Limited, Estilo Moderno Realty Private Limited and 1 more
Whole-Time Director30 Sep 200422 Years 1 MonthsCurrent
Suriakiran Umacanta SinaikundeDirector25 Oct 201412 Years 0 MonthsCurrent
View all directors

Peer comparison

Geno Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mepro Pharmaceuticals Private Limited₹356.46 Cr (FY 2025)20.0%Surendra Nagar, Gujarat, India
Bharat Parenterals Limited₹352 Cr (FY 2025)32.0%Vadodara, Gujarat, India
Geno Pharmaceuticals Private Limitedthis company₹349.47 Cr (FY 2025)₹36.05 Cr10.3%14.0%1,042Goa, India
Sparsh Bio-Tech Private Limited₹346.49 Cr (FY 2025)-29.0%Jamnagar, Gujarat, India
Capsugel Healthcare Private Limited₹340.69 Cr (FY 2025)9.0%Gurugram, Haryana, India
Walter Bushnell Enterprises Private Limited₹340.47 Cr (FY 2025)132.0%Mumbai, Maharashtra, India
Ozone Pharmaceuticals Limited₹337.45 Cr (FY 2025)-1.0%New Delhi, Delhi, India
G.D. Pharmaceuticals Private Limited₹334.15 Cr (FY 2025)26.0%Kolkata, West Bengal, India

To see the full peer comparison of Geno Pharmaceuticals Private Limited, buy the company report.

Auditor

Geno Pharmaceuticals Private Limited is audited by R. K. Pikale & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
R. K. Pikale & Co.FY 2023107919W

Shareholding

The shareholding of Geno Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Geno Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹136.64 Cr
Satisfied charges
₹96.95 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹89.39 Cr
Canara Bank₹43.00 Cr
State Bank of India₹4.23 Cr
Mapusa Urban Co-Operation Ltd.₹0.02 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Sep 2025101165122Hdfc Bank Limited₹4.39 CrOpen
01 Sep 2025101147312Hdfc Bank Limited₹85 CrOpen
11 Mar 2022100554723State Bank of India₹4.23 CrOpen
26 Dec 201310470582Canara Bank₹43 CrOpen
18 Nov 198390076992Mapusa Urban Co-Operation Ltd.₹2 LakhOpen

To see the full charge records of Geno Pharmaceuticals Private Limited, buy the company report.

Total charge records: 26 View all charges

Credit ratings & regulatory alerts

Geno Pharmaceuticals Private Limited was last rated by Crisil on 10 Dec 2020.

Rating agencyRated onRating
Crisil10 Dec 2020

To see the full credit ratings and regulatory alerts of Geno Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

Geno Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 66 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 20)

SupplierAmount dueDue sinceReported on
Rukmini Pack Print Private Limited
Electrolab (India) Private Limited
Bharat Chemicals
Sudeep Pharma Limited
Ashapura Drugs

To see the full MSME payment records of Geno Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Geno Pharmaceuticals Private Limited has a workforce of 1,042 employees on its EPFO records as of Jan 30, 2026, across 1 active EPFO establishment.

Employee count
1,042
Active EPFO establishments
1
Employee growth
-5.53%

GST

Geno Pharmaceuticals has 25 GST registrations: 20 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
25
Active
20
Cancelled / inactive
5
GSTINStateStatusRegistered on
30AAACG5887G1ZOGoaActive01 Jul 2017
30AAACG5887G3ZMGoaActive24 Mar 2025
03AAACG5887G1ZLPunjabActive01 Jul 2017
07AAACG5887G1ZDDelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Geno Pharmaceuticals Private Limited, buy the company report.

Recent activity

Geno Pharmaceuticals Private Limited has 19 board changes on record since 1980: 6 appointments and 13 cessations. The latest: Shivam Sagar Salgaocar ceased to be Additional Director on 29 Sep 2024.

AGM
Geno Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.39 Cr with Charge ID 101165122 was registered on 25 Sep 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 85.00 Cr registered on 01 Sep 2025 with Charge ID 101147312 was modified on 08 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 85.00 Cr with Charge ID 101147312 was registered on 01 Sep 2025.
Charges
A charge with Canara Bank of Rs. 43.00 Cr registered on 26 Dec 2013 with Charge ID 10470582 was modified on 29 May 2025.
Charges
A charge registered on 09 Mar 2022 via Charge ID 100554721 with Others was fully satisfied on 16 Apr 2025.
Filing
Geno Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa.
Ceased
Shivam Sagar Salgaocar ceased to be Additional Director.
Appointed
Shivam Sagar Salgaocar was appointed as Director.
Ceased
Pradip Prabhakar Mahatme ceased to be Director.
Charges
A charge registered on 02 Dec 2019 via Charge ID 100310312 with Others was fully satisfied on 31 Mar 2022.
Charges
A charge with State Bank Of India amounted to Rs. 4.23 Cr with Charge ID 100554723 was registered on 11 Mar 2022.

71 earlier events are in the company report.

News

Frequently asked questions

Geno Pharmaceuticals is an active private limited company based in Goa, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 December 1975 (51+ years old) and is registered under CIN U24239GA1975PTC000250.

Geno Pharmaceuticals has 6 current directors:

The latest financial statements of Geno Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Geno Pharmaceuticals is 30AAACG5887G1ZO, registered in Goa. The company has 25 GST registrations in all, of which 20 are active and 5 are cancelled or inactive. Other active GSTINs include 30AAACG5887G3ZM (Goa), 03AAACG5887G1ZL (Punjab), 07AAACG5887G1ZD (Delhi).

The CIN (Corporate Identification Number) of Geno Pharmaceuticals is U24239GA1975PTC000250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Geno Pharmaceuticals has 85 court cases on record: 55 filed by the company and 30 filed against it. 13 are pending. Most are in the high courts.

Geno Pharmaceuticals was incorporated on 04 December 1975, making it 51+ years old. It is registered with the Registrar of Companies, Goa.

The peers of Geno Pharmaceuticals by revenue are Mepro Pharmaceuticals Private Limited, Bharat Parenterals Limited, Sparsh Bio-Tech Private Limited, Capsugel Healthcare Private Limited, Walter Bushnell Enterprises Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Shivam Sagar Salgaocar ceased to be Additional Director on 29 Sep 2024. Shivam Sagar Salgaocar was appointed as Director on 23 Oct 2023. Pradip Prabhakar Mahatme ceased to be Director on 08 Apr 2022. Geno Pharmaceuticals has 19 board changes on record in total.

Yes, Geno Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GA-01-0002168).

Geno Pharmaceuticals has 5 MSME Form 1 returns on record between 2019 and 2022, listing 66 overdue payments to 20 micro and small suppliers. The latest return was filed on 17 Jun 2022.

Geno Pharmaceuticals can be reached through the website genopharma.com. Its registered office is in Goa, India.